View in EDS

Neoantigen Targeting as a Novel Approach for Therapy-Resistant Tumors.

Saved in:

Bibliographic Details
Title:	Neoantigen Targeting as a Novel Approach for Therapy-Resistant Tumors.
Authors:	Okada M; Laboratory for Immunotherapy, RIKEN Center for Integrative Medical Sciences, 1-7-22, Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa, 230-0045, Japan., Yamasaki S; Laboratory for Immunotherapy, RIKEN Center for Integrative Medical Sciences, 1-7-22, Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa, 230-0045, Japan., Sato GR; Laboratory for Immunotherapy, RIKEN Center for Integrative Medical Sciences, 1-7-22, Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa, 230-0045, Japan., Shimizu K; Laboratory for Immunotherapy, RIKEN Center for Integrative Medical Sciences, 1-7-22, Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa, 230-0045, Japan., Fujii SI; Laboratory for Immunotherapy, RIKEN Center for Integrative Medical Sciences, 1-7-22, Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa, 230-0045, Japan. shin-ichiro.fujii@riken.jp.; RIKEN Program for Drug Discovery and Medical Technology Platforms, RIKEN, Yokohama, Kanagawa, Japan. shin-ichiro.fujii@riken.jp.
Source:	Molecular diagnosis & therapy [Mol Diagn Ther] 2026 May; Vol. 30 (3), pp. 495-514. Date of Electronic Publication: 2026 Mar 30.
Publication Type:	Journal Article; Review
Journal Info:	Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 101264260 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2000 (Electronic) Linking ISSN: 11771062 NLM ISO Abbreviation: Mol Diagn Ther Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1179-2000
DOI:	10.1007/s40291-026-00842-9